Nu Skin Enterprises, Inc. (NYSE:NUS) was the recipient of unusually large options trading on Monday. Stock investors bought 1,793 put options on the stock. This represents an increase of 936% compared to the typical volume of 173 put options.
In related news, Chairman Steven Lund sold 42,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.11, for a total transaction of $2,860,620.00. Following the completion of the sale, the chairman now directly owns 4,769 shares in the company, valued at $324,816.59. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 195,978 shares of company stock valued at $13,512,733 over the last quarter. 5.20% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in NUS. Wolverine Asset Management LLC grew its holdings in shares of Nu Skin Enterprises by 106.9% during the 4th quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock worth $103,000 after purchasing an additional 23,378 shares during the period. Cerebellum GP LLC purchased a new position in shares of Nu Skin Enterprises during the 4th quarter worth $124,000. Migdal Insurance & Financial Holdings Ltd. purchased a new position in shares of Nu Skin Enterprises during the 3rd quarter worth $148,000. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Nu Skin Enterprises during the 4th quarter worth $192,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Nu Skin Enterprises by 38.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after purchasing an additional 858 shares during the period. Institutional investors and hedge funds own 76.17% of the company’s stock.
Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.01. The business had revenue of $666.20 million during the quarter, compared to analysts’ expectations of $667.39 million. Nu Skin Enterprises had a return on equity of 25.23% and a net margin of 5.68%. The company’s revenue was up 25.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.79 EPS. equities research analysts anticipate that Nu Skin Enterprises will post 3.55 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 14th. Stockholders of record on Monday, February 26th will be issued a dividend of $0.365 per share. The ex-dividend date of this dividend is Friday, February 23rd. This is a boost from Nu Skin Enterprises’s previous quarterly dividend of $0.36. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.11%. Nu Skin Enterprises’s dividend payout ratio is currently 60.76%.
NUS has been the subject of several analyst reports. ValuEngine upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Tuesday, November 14th. Deutsche Bank upped their target price on Nu Skin Enterprises from $75.00 to $77.00 and gave the company a “buy” rating in a report on Friday. Pivotal Research restated a “buy” rating and issued a $90.00 target price on shares of Nu Skin Enterprises in a report on Friday. Citigroup restated a “buy” rating and issued a $81.00 target price (up from $70.00) on shares of Nu Skin Enterprises in a report on Tuesday, January 23rd. Finally, Zacks Investment Research upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 target price for the company in a report on Saturday, December 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and a consensus price target of $71.29.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2018/02/20/nu-skin-enterprises-sees-unusually-high-options-volume-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.